Additionally, ERK phosphorylation as an indicator of active intrinsic signaling may be a better predictor than expression of known clinically relevant markers as it was shown for Akt phosphorylation compared to epidermal growth factor receptor expression in non-small cell lung cancer in relation to gefitinib response [21]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.